Sunday 8 August 2021

FDA updates its database about all licensed biological products


The FDA has recently updated the “Purple Book” — a database containing information about all licensed biological products — new additions include patent information relating to biologics as well as FDA regulatory exclusivity information.


According to Pharmaceutical Online, the directory provides the opportunity for:

(i) potential partnerships for licensing of existing intellectual property;

(ii) new strategies regarding intellectual property enforcement and protection; and, potentially,

(iii) opportunities for the development of new technology.

Here is the link: 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (

No comments:

Post a Comment

Pharmaceutical Microbiology Resources

Special offers